Stryker (SYK) Stock Price, News & Analysis

Company Overview

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment. Stryker also develops and supports robotic-assisted surgical systems and associated software aimed at improving procedural precision and outcomes.

Founded in 1941 by Dr. Homer Stryker, the company has grown through ongoing product development and strategic acquisitions to expand its technology portfolio and geographic reach. Stryker’s offerings include implants, capital equipment, instruments, disposables and digital solutions, together with training, service and clinical support for healthcare providers. The company serves a global customer base of hospitals, outpatient centers, clinicians and emergency responders and emphasizes research and development, clinical collaborations and post-market support to drive innovation and adoption.

Headquartered in Kalamazoo, Michigan, Stryker operates manufacturing, research and distribution facilities around the world and sells its products in numerous international markets across the Americas, Europe, Asia Pacific and other regions. The company is managed by an executive leadership team and overseen by a board of directors; its operations place ongoing emphasis on regulatory compliance, quality systems, clinical evidence generation and partnerships with healthcare professionals to advance patient care.

Key Stats

• Today's Range: $312.43 to $318.90
• 50-Day Range: $282.85 to $349.89
• 52-Week Range: $281.00 to $404.87
• Volume: 1.89 million shs
• Average Volume: 2.99 million shs
• Market Capitalization: $121.29 billion
• P/E Ratio: 36.62
• Dividend Yield: 1.11%
• Price Target: $395.48
• Consensus Rating: Moderate Buy

Stryker Stock Analysis - MarketRank™

Stryker scored higher than 100% of companies evaluated by MarketBeat, and ranked 2nd out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 16 buy ratings, 6 hold ratings, and no sell ratings.

Upside Potential

Stryker has a consensus price target of $395.48, representing about 25.0% upside from its current price of $316.39.

Amount of Analyst Coverage

Stryker has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 11.01%

Earnings Growth

Earnings for Stryker are expected to grow by 11.01% in the coming year, from $14.98 to $16.63 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Stryker is 36.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of Stryker is 36.62, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.02.

Price to Earnings Growth Ratio

Stryker has a PEG Ratio of 1.98. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Stryker has a P/B Ratio of 5.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.21% of the float of Stryker has been sold short.

Short Interest Ratio / Days to Cover

Stryker has a short interest ratio ("days to cover") of 2.21, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Stryker has recently decreased by 6.46%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Stryker pays a meaningful dividend of 1.09%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Stryker has been increasing its dividend for 32 years.

Dividend Coverage

The dividend payout ratio of Stryker is 40.74%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Stryker will have a dividend payout ratio of 21.17% next year. This indicates that Stryker will be able to sustain or increase its dividend.

News and Social Media

• Score: 4.4 / 5
• News Sentiment: 1.08

News Sentiment

Stryker has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 20 news articles for Stryker this week, compared to 8 articles on an average week.

Search Interest

46 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 64% compared to the previous 30 days.

MarketBeat Follows

19 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 375% compared to the previous 30 days.

Company Ownership

• Score: 1.6 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,473,772.00 in company stock.

Percentage Held by Insiders

4.60% of the stock of Stryker is held by insiders.

Percentage Held by Institutions

77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 4/30 Dividend: 3/31/2026
• Ex-Dividend for 4/30 Dividend: 3/31/2026
• Last Earnings: 4/30/2026
• Dividend Payable: 4/30/2026
• Today: 5/23/2026
• Next Earnings (Estimated): 7/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SYK
• CIK: 310764
• Web: www.strykercorp.com
• Phone: (269) 385-2600
• Fax: 269-385-1062
• Employees: 56,000
• Year Founded: 1941

Price Target and Rating

• Average Price Target for Stryker: $395.48
• High Price Target: $465.00
• Low Price Target: $315.00
• Potential Upside/Downside: +25.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.73
• Research Coverage: 22 Analysts

Profitability

• EPS (Trailing Twelve Months): $8.64
• Trailing P/E Ratio: 36.62
• Forward P/E Ratio: 21.12
• P/E Growth: 1.98
• Net Income: $3.25 billion
• Net Margins: 13.20%
• Pretax Margin: 18.20%
• Return on Equity: 23.42%
• Return on Assets: 11.04%

Debt

• Debt-to-Equity Ratio: 0.62
• Current Ratio: 2.11
• Quick Ratio: 1.25

Sales & Book Value

• Annual Sales: $25.27 billion
• Price / Sales: 4.80
• Cash Flow: $17.05 per share
• Price / Cash Flow: 18.56
• Book Value: $59.94 per share
• Price / Book: 5.28

Miscellaneous

• Outstanding Shares: 383,361,000
• Free Float: 365,726,000
• Market Cap: $121.29 billion
• Optionable: Optionable
• Beta: 0.80